Ontario funds new regenerative medicine organization to speed commercialization. Re$earch Money, December 10, 2014.

New institute to study regenerative medicine. Lab Products News, Dec. 3, 2014.

Government of Ontario, OSCI and CCRM launch new regenerative medicine institute. Biotechnology Focus, Nov. 28, 2014.

L’Ontario soutient des travaux de recherche revolutionnaires sur les cellules souches. La gazette du Laboratoire, le 27 novembre, 2014.

Ontario announces funding for stem cell institute. The Globe and Mail, Nov. 25, 2015

Historic $130-million gift to establish the Ted Rogers Centre for Heart Research. U of T Engineering News, Nov. 20, 2014.

Super Cells exhibit and why we bother with public outreach. Knoepfler Lab Stem Cell Blog, Nov. 12, 2014.

New stem cell action plan promises major leap forward in alleviating human suffering. Biotechnology Focus, Nov. 6, 2014.

Ebola Watch: The Importance of Stopping Contamination. Laboratory Equipment, Nov. 6, 2014.

Medical groups call for $1.5B stem cell investment. CTV News, Oct. 29, 2014.

Coalition calls on Ottawa to commit $500M for stem cell research. The Globe and Mail, Oct. 29, 2014.

Video: New push for stem cell research funding. Global News, Oct. 29, 2014.

Medical groups call for major stem cell investment from public-private sector. CTV News, Oct. 29, 2014.

Ottawa hosts global leaders in stem cell and regenerative medicine research. Biotechnology Focus, Oct. 27, 2014.

Canadian Stem Cell Experts Gather for Till-McCulloch 2014. Forbes, Oct. 27, 2014.

Building Canada’s Strengths: Regenerative Medicine – Canada’s rise as an international powerhouse in stem cell research is no accident. nce-rce.gc.ca 2014

Highlights from the Business of Regenerative Medicine Course. Biotechnology Focus, Oct/Nov 2014.

The ethics of using stem cells for enhancement. JaneLangille.com, Oct. 14, 2014.

Building a superhuman: Stem cell advances are leading to dangers and ethical problems few have considered. Calgary Herald, Oct. 5, 2014.

Op-Ed: “Stem Cell Superheroes and the Limits of Our Biology” Special. Digital Journal, Oct. 4, 2014.

Partnering to build the global regenmed industry. Regen Magazine 2014.

Une nouvelle exposition sur les cellules souches au Musee de la nature et des sciences. Estrieplus.com, Sept. 29, 2014.

New compound developed for cord blood expansion. Lab Product News, Sept. 23, 2014.

CCRM and RepliCel partner on development of cell therapies for tendon repair. Biotechnology Focus, Sept. 8, 2014.

Cell Science Citizens: From the Petri Dish to the Clinic. The International Network for Knowledge about Wellbeing, Sept. 8, 2014.

Some academics worry if Canada’s commitment to fund commercial research over basic science will backfire (podcast). “The Current” from CBC Radio, Sept. 5, 2014.

CCRM uses ambr15 for Pluripotent Stem Cell Expansion and Differentiation Research. Lab Bulletin, August 21, 2014.

‘De-risking’ Stem Cell Therapy with Government Cash and Assistance. California Stem Cell Report blog, August 18, 2014.

Therapies of the state  Nature Biotechnology, August 05, 2014.

Thirteen more companies join CCRM’s industry consortium. Biotechnology Focus, July 25, 2014.

Cell Therapy Commercialization: Look for Headroom. BioteCanada Insights, Summer issue 2014.

BDC Capital Announces $500,000 Convertible Notes for Canadian Healthtech Startups. Now Digital Network, June 26, 2014.

New BDC-Backed Accel-Rx Health Sciences Accelerator Will Give Startups $500,000. BetaKit, June 25, 2014.

Culturing growth: How an idea from BC Cancer Agency grew into Canada’s biggest stem cell business venture. The Vancouver Sun, June 21, 2014.

Canada Australia to collaborate in stem cell research. Lab Product News, June 17, 2014.

The Real Deal on Stem Cell Therapies. Vancouver Magazine, June 17, 2014.

Panelists: Positives amid setbacks in cell therapy, regenerative medicine space. Bioworld Today, May 22, 2014.

The role of translational centers in regenerative medicine industry. Stem Cell Assays, May 21, 2014.

CCRM and Hemostemix to partner on developing cell therapies for cardiovascular disease. Biotechnology Focus, May 06, 2014.

California Stem Cell Institute Picks Industry Veteran as President. American Association for the Advancement of Science, April 30, 2014.

Podcast of Michael May on cell therapy reimbursement obstacles in the UK and North America. BioProcess International.

Stem cells donation campaign on [Humber] campus. Humber Et Cetera, March 14, 2014.

Opening the door to opportunity in Singapore and Japan. Biotechnology Focus, January 29, 2014.

The stem of the matter. Canadian Institute of Canada. January 2014.

Stem Cell Blog of the Year 2013: Signals Blog by Stem Cell Network/CCRM. Knoepfler Lab Stem Cell Blog, December 10, 2013.

[Regener8] investigates translation the North American way. Regen, December 2013.

CCRM: Moving Forward with Regenerative Medicine Commercialization in Canada. Stem Cells and Development: World Stem Cell Report, Vol. 22, Issue S1.

Taking the pulse – indicators of strength and growth in the RM industry. Biotechnology Focus, November 25, 2013.

What composes the human heart? Researchers crunch the numbers. PHYS ORG, November 20, 2013.

IBBME Focal Point: Peter Zandstra (podcast). IBBME Focal Point, November 1, 2013

Collaboration and convergence – Indicators of strength and growth in RegenMed. Regen, October 2013, Issue 4.

Stem cells: how to predict their fate. U of T News, October 22, 2013. 

360ip and CCRM join forces to source best IP in regenerative medicine. Biotechnology Focus, October 17, 2013. 

[Peter Zandstra] behind Canadian stem cell technology recognized with Till & McCulloch Award. Biotechnology Focus, October 2, 2013.

Industry consortium key – New model aims to capitalize on Canada’s world-class strength in regenerative medicine. Re$earch Money, August 27, 2013.

Video of RM leaders, including CCRM’s Peter Zandstra, on the emergence of stem cell engineering. YouTube, August 13, 2013.

Interview [with Peter Zandstra]: The bioprocessing of stem cells: how to reach the clinic. Future Medicine: Regenerative Medicine, July 2013, Vol. 8

Setting the standard for cell therapy: Project update. Foreign and Commonwealth Office Blogs, June 25, 2013.

ISSCR 2013 Part 5: Centre for Commercialization of Regenerative Medicine. The Center for Medical Progress (video). June 21, 2013.

Cell therapy and regenerative medicine centres in Canada and UK to work together. Biotechnology Focus, June 10, 2013.

Guest blog: Predictive surrogate assays could drive efficient clinical translation and commercialization. BioPortfolio.com, June 5, 2013. 

Cell therapy and regenerative medicine centres in Canada and UK to collaborate. Manufacturing Chemist, May 31, 2013. 

Stem cell patents – Securing intellectual property for regenerative medicine. Biotechnology Focus, April 2013.

No frivolity here: 15 stem cell experts and 10 news sources to follow on Twitter. MEDCity News, April 5, 2013.

Multi-imaging stem cells in real time. Forbes, March 8, 2013.

Stem cell development companies could regenerate into higher profits in 2013. Market Playground, March 4, 2013.

Sernova and CCRM partner to treat chronic diseases. Biotechnology Focus, March 1, 2013.

CCRM implements ethics unit to promote responsible research. Laboratory Focus, February 25, 2013.

Insception, largest cord blood bank in Canada, joins CCRM Consortium. IBBME News, February 6, 2013.

Everything you Need [Toronto is a great biotech hub]. BioBusiness, Jan/Feb 2013.

Technologies evolving for cellular therapies. Genetic Engineering and Biotechnology News, Jan. 15, 2013.

Integrating engineering and health care – It’s not all about technology. Engineering Dimensions, Nov/Dec 2012.

Global update: Canada. World Stem Cell Report, Regen. Med. 7(6 Suppl.) (2012)

Efforts to commercialize regenerative medicine in Canada growing steadily. Biotechnology Focus, December 2012, Vol. 15 #11

Regenerative medicine could experience growth spurt. The Newspaper, November 14, 2012. 

Tomorrow’s Technology: Regenerative Medicine. U of T News, October 30, 2012.

Biomedical symposium features local and international talent. Varsity, October 22, 2012.

Small and mighty: Stem cells hold great promise for Canada. National Post (supplement), September 2012

Feds investing more in science and technology ‘than ever in the history of our nation,’ says Goodyear. Hill Times, September 10, 2012.

Canada’s life sciences industry split on Canada-EU free trade agreement. Hill Times, September 10, 2012.

It’s time to nurture an emerging Canadian regenerative medicine industry. Op-Ed by Michael May. Hill Times, September 10, 2012.

There’s Always a Way. IBBME, Innovators and Entrepreneurs, July 30, 2012.

U of T Engineering Professor [CCRM’s Peter Zandstra] Joins International Advisory Committee. U of T News, July 12, 2012.

CCRM – Strategic Partnerships Are Paying Off. Biotechnology Focus, July 2012.

OSCI: The Ties That Bind. Biotechnology Focus, July 2012.

Inventors of the Year. U of T News, June 11, 2012.

Scientists learn how to turn skin cells into heart muscle. Canada AM (CTV), May 23, 2012. 

Stem cells to optimize match between patient and medication. Financial Post (Smart Shift series), May 15, 2012. 

Reasons to LOVE Toronto Now. Toronto Life, June 2012.

Collaboration Will Create Disruption in Regenerative Medicine. Business Strategy blog, May 13, 2012.

Toronto: Canada’s startup and entrepreneurial capital. U of T News, May 1, 2012.

New fund for regenerative medicine industry. Benefits Canada, May 1, 2012.

VistaGen Therapeutics takes part in international collaborative medicine effort. MissionIR, March 30, 2012.

Toronto non-profit and Millipore collaborate to design stem cell bioreactor. TechVibes, March 13, 2012.  

Millipore and Toronto non-profit cultivate stem cells in bioreactor. Mass High Tech, March 12, 2012.

EMD Millipore, CCRM optimize large-scale stem cell cultivation. Genetic Engineering & Biotechnology News, March 12, 2012.

EMD Millipore and CCRM collaborate on stem cell cultivation. Patexia, March 13, 2012.

Large-scale stem cell cultivation partnership formalized. U of T News, March 6, 2012. 

Innovation hub forming in Banting and Best complex. U of T Research & Innovation, October 12, 2011.

Commercialisation of Regenerative Medicine. Pharma IQ, September 20, 2011.

OSCI and CCRM: ensuring Ontario’s regenerative medicine legacy lives on. Biotechnology Focus, June 2011, Vol. 14, Number 6.

Taking the pulse – indicators of strength and growth in the RM industry. Biotechnology Focus, November 25, 2013.

What composes the human heart? Researchers crunch the numbers. PHYS ORG, November 20, 2013.

Collaboration and convergence – Indicators of strength and growth in RegenMed. Regen, October 2013, Issue 4.

Stem cells: how to predict their fate. U of T News, October 22, 2013.

360ip and CCRM join forces to source best IP in regenerative medicine. Biotechnology Focus, October 17, 2013.

[Peter Zandstra] behind Canadian stem cell technology recognized with Till & McCulloch Award. Biotechnology Focus, October 2, 2013.

Video of RM leaders, including CCRM’s Peter Zandstra, on the emergence of stem cell engineering. YouTube, August 13, 2013.

Interview [with Peter Zandstra]: The bioprocessing of stem cells: how to reach the clinic. Future Medicine: Regenerative Medicine, July 2013, Vol. 8

Setting the standard for cell therapy: Project update. Foreign and Commonwealth Office Blogs, June 25, 2013.

ISSCR 2013 Part 5: Centre for Commercialization of Regenerative Medicine. The Center for Medical Progress (video). June 21, 2013.

Cell therapy and regenerative medicine centres in Canada and UK to work together. Biotechnology Focus, June 10, 2013.

Guest blog: Predictive surrogate assays could drive efficient clinical translation and commercialization. BioPortfolio.com, June 5, 2013.

Cell therapy and regenerative medicine centres in Canada and UK to collaborate. Manufacturing Chemist, May 31, 2013.

Stem cell patents – Securing intellectual property for regenerative medicine. Biotechnology Focus, April 2013.

No frivolity here: 15 stem cell experts and 10 news sources to follow on Twitter. MEDCity News, April 5, 2013.

Everything you Need [Toronto is a great biotech hub]. BioBusiness, Jan/Feb 2013.

Multi-imaging stem cells in real time. Forbes, March 8, 2013.

Stem cell development companies could regenerate into higher profits in 2013. Market Playground, March 4, 2013.

Sernova and CCRM partner to treat chronic diseases. Biotechnology Focus, March 1, 2013.

CCRM implements ethics unit to promote responsible research. Laboratory Focus, February 25, 2013.

Insception, largest cord blood bank in Canada, joins CCRM Consortium. IBBME News, February 6, 2013.

Technologies evolving for cellular therapies. Genetic Engineering and Biotechnology News, Jan. 15, 2013.

Integrating engineering and health care – It’s not all about technology. Engineering Dimensions, Nov/Dec 2012.

Global update: Canada. World Stem Cell Report, Regen. Med. 7(6 Suppl.) (2012)

Efforts to commercialize regenerative medicine in Canada growing steadily. Biotechnology Focus, December 2012, Vol. 15 #11

Regenerative medicine could experience growth spurt. The Newspaper, November 14, 2012.

Tomorrow’s Technology: Regenerative Medicine. U of T News, October 30, 2012.

Biomedical symposium features local and international talent. Varsity, October 22, 2012.

Feds investing more in science and technology ‘than ever in the history of our nation,’ says Goodyear. Hill Times, September 10, 2012.

Canada’s life sciences industry split on Canada-EU free trade agreement. Hill Times, September 10, 2012.

It’s time to nurture an emerging Canadian regenerative medicine industry. Op-Ed by Michael May. Hill Times, September 10, 2012.

There’s Always a Way. IBBME, Innovators and Entrepreneurs, July 30, 2012.

U of T Engineering Professor [CCRM’s Peter Zandstra] Joins International Advisory Committee. U of T News, July 12, 2012.

CCRM – Strategic Partnerships Are Paying Off. Biotechnology Focus, July 2012.

OSCI: The Ties That Bind. Biotechnology Focus, July 2012.

Inventors of the Year. U of T News, June 11, 2012.

Scientists learn how to turn skin cells into heart muscle. Canada AM (CTV), May 23, 2012.

Stem cells to optimize match between patient and medication. Financial Post (Smart Shift series), May 15, 2012.

Reasons to LOVE Toronto Now. Toronto Life, June 2012.

Collaboration will Create Disruption in Regenerative Medicine. Business Strategy blog, May 13, 2012.

Toronto: Canada’s startup and entrepreneurial capital. U of T News, May 1, 2012.

New fund for regenerative medicine industry. Benefits Canada, May 1, 2012.

VistaGen Therapeutics takes part in international collaborative medicine effort. MissionIR, March 30, 2012.

Toronto non-profit and Millipore collaborate to design stem cell bioreactor. TechVibes, March 13, 2012.

Millipore and Toronto non-profit cultivate stem cells in bioreactor. Mass High Tech, March 12, 2012.

EMD Millipore, CCRM optimize large-scale stem cell cultivation. Genetic Engineering & Biotechnology News, March 12, 2012.

EMD Millipore and CCRM collaborate on stem cell cultivation. Patexia, March 13, 2012.

Large-scale stem cell cultivation partnership formalized. U of T News, March 6, 2012.

Innovation hub forming in Banting and Best complex. U of T Research & Innovation, October 12, 2011.

Commercialisation of Regenerative Medicine. Pharma IQ, September 20, 2011.

OSCI and CCRM: ensuring Ontario’s regenerative medicine legacy lives on. Biotechnology Focus, June 2011, Vol. 14, Number 6.